Midday Report: Enlivex (ENLV) Gains on August 5

Equities Staff  |

Enlivex Therapeutics Ltd (NASDAQ: ENLV) shares moved 7.98%, or $0.38 per share, as on 11:49:36 est today. Since opening at $5.12, 22,975 shares of Enlivex have traded hands and the stock has moved between $5.26 and $5.04.  

Already this year the company has a YTD change of 18.88%.

Enlivex anticipates its next earnings on 2022-08-08.

For technical charts, analysis, and more on Enlivex visit the company profile.

About Enlivex Therapeutics Ltd

Enlivex is a clinical stage immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. Resetting non-homeostatic macrophages into their homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions.

To get more information on Enlivex Therapeutics Ltd and to follow the company's latest updates, you can visit the company's profile page here: Enlivex Therapeutics Ltd's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content